EUVIMEDEUVIMED entdecken
Crossref

A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism

Mehrdad Yazdanpanah, Sarah R Delaney, Daniel R Beriault iD

Clinical Chemistry · 2023

DOI: 10.1093/clinchem/hvad065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2023. Verfasst von Mehrdad Yazdanpanah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, St. Michael's Hospital, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Aldosterone, Hyperaldosteronism. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary aldosteronism (PA) is a common endocrine cause of secondary hypertension. The aldosterone/renin ratio is an important tool for PA screening, and dynamic testing in serum or urine is used to confirm the diagnosis. While LC-MS/MS is considered the gold standard for testing, there is significant interlaboratory variability between the extraction procedures, which can impact diagnostic interpretation. To help overcome this, we present a simple and accurate LC-MS/MS method for the quantification of both serum and urine aldosterone using a novel enzymatic hydrolysis procedure.

Methods

Serum and urine aldosterone was extracted and measured by LC-MS/MS. Urine-conjugated aldosterone glucuronide was hydrolyzed using a genetically modified glucuronidase enzyme. The assay precision, accuracy, limit of quantification, recovery, and carryover were evaluated and the new assay cut-offs were proposed.

Results

The liquid chromatography method allowed for adequate separation of the aldosterone peak from closely eluting peaks. Significant in vitro aldosterone loss was observed during acid-catalyzed hydrolysis of urine, which was corrected with the addition of the internal standard to the urine before the hydrolysis step. Glucuronidase catalyzed hydrolysis of urine aldosterone glucuronide displays good correlation with the corrected acid-catalyzed hydrolysis. Serum aldosterone showed good agreement with reference values and the consensus range reported for external quality assessment specimens.

Conclusion

A simple, fast, and highly accurate method for the detection of serum and urine aldosterone has been developed. The proposed novel enzymatic procedure allows for short hydrolysis time and compensates for urine aldosterone loss during the hydrolysis step.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AldosteroneHyperaldosteronismHumansChromatography, LiquidHydrolysisGlucuronidesTandem Mass SpectrometryGlucuronidase

Substanzen

AldosteroneGlucuronidesGlucuronidase

Autor:innen und Institutionen

  • Department of Laboratory Medicine, St. Michael's Hospital, Toronto, ON, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.

ORCID-Profile: Daniel R Beriault

Zitieren

APA

Yazdanpanah, M., Delaney, S. R., & Beriault, D. R. (2023). A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvad065

Vancouver

Yazdanpanah M, Delaney SR, Beriault DR. A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism. Clinical Chemistry. 2023. doi:10.1093/clinchem/hvad065

BibTeX
@article{Yazdanpanah2023,
  author = {Yazdanpanah, Mehrdad and Delaney, Sarah R and Beriault, Daniel R},
  title = {A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism},
  journal = {Clinical Chemistry},
  year = {2023},
  doi = {10.1093/clinchem/hvad065}
}
Kostenlos starten →